Health In Tech reaffirmed its full-year 2026 revenue guidance of $45 million to $50 million during its second-quarter earnings call. The company reported second-quarter revenue of $8.1 million, down 13.5% from $9.3 million a year earlier, and a net loss of $2.5 million, or $0.04 per diluted share. Management attributed the revenue decline to a timing shift caused by onboarding a new carrier partner, which pushed some policy placements into later quarters. The company highlighted contracted revenue of $32.3 million for the first half of 2026 and pipeline revenue of $66.3 million as of July 31. Health In Tech also said it expects to launch its HitRix platform within the next two to three weeks and is transitioning to an A-rated carrier within about 30 days to expand access to larger brokers.
Health In Tech, Inc. Class A Common StockReaffirms 2026 revenue guidance and reports contracted revenue, despite Q2 decline.
